Serum endotrophin identifies optimal responders to PPARĪ³ agonists in type 2 diabetes
Crossref DOI link: https://doi.org/10.1007/s00125-016-4094-1
Published Online: 2016-09-08
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Karsdal, Morten A.
Henriksen, Kim
Genovese, Federica
Leeming, Diana J.
Nielsen, Mette J.
Riis, Bente J.
Christiansen, Claus
Byrjalsen, Inger
Schuppan, Detlef
License valid from 2016-09-08